E H Oldfield Selected Research

E H Oldfield Research Topics

Disease

11	Neoplasms (Cancer) 03/2006 - 01/2000
4	Cushing Syndrome 12/2006 - 01/2000
4	Pituitary Neoplasms (Pituitary Adenoma) 09/2001 - 03/2000
3	Infarction (Infarctions) 04/2001 - 04/2000
3	Reperfusion Injury 04/2001 - 04/2000
2	Stroke (Strokes) 04/2001 - 04/2000
2	Ischemia 04/2001 - 04/2000
1	Disease Progression 01/2007
1	Gaucher Disease (Gaucher's Disease) 01/2007
1	Pituitary ACTH Hypersecretion 12/2006
1	Astrocytoma (Pilocytic Astrocytoma) 03/2006
1	Meningioma (Meningiomas) 12/2001
1	Glioblastoma (Glioblastoma Multiforme) 12/2001
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 12/2001
1	Crush Injuries 12/2001
1	Peripheral Nerve Injuries 12/2001
1	Lymphoma (Lymphomas) 10/2001
1	Medulloblastoma 10/2001
1	Neuroblastoma 10/2001
1	Rhabdomyosarcoma 10/2001
1	Ewing Sarcoma (Sarcoma, Ewing) 10/2001
1	Primitive Neuroectodermal Tumors (PNET) 10/2001
1	Hyperthyroidism 08/2001
1	Residual Neoplasm 08/2001
1	Intracranial Embolism 04/2001
1	Hypoxia (Hypoxemia) 03/2001
1	Prolactinoma (Prolactinomas) 11/2000
1	Ischemic Stroke 07/2000
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2000
1	Acromegaly 03/2000
1	Carney Complex 03/2000
1	Gigantism 03/2000
1	Radiculopathy (Radiculopathy, Cervical) 02/2000
1	Paraplegia (Spastic Paraplegia) 02/2000
1	Spontaneous Fractures (Pathological Fracture) 02/2000
1	Hemangioma (Angioma) 02/2000
1	Glioma (Gliomas) 01/2000
1	Hemorrhage 01/2000
1	Thrombosis (Thrombus) 01/2000
1	Brain Neoplasms (Brain Tumor) 01/2000
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2000
1	Intracranial Vasospasm 01/2000
1	Spasm (Spasms) 01/2000

Drug/Important Bio-Agent (IBA)

4	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2006 - 01/2000
3	EnzymesIBA 01/2007 - 01/2000
3	DNA (Deoxyribonucleic Acid)IBA 12/2001 - 12/2000
2	Thyroid HormonesIBA 11/2001 - 09/2001
2	Oxygen (Dioxygen)IBA 04/2001 - 07/2000
2	Free RadicalsIBA 04/2001 - 07/2000
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2001 - 04/2000
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2001 - 01/2000
2	Growth Hormone (Somatotropin)IBA 11/2000 - 03/2000
1	Glucosylceramidase (Glucocerebrosidase)IBA 01/2007
1	Proteins (Proteins, Gene)FDA Link 03/2006
1	Tumor Biomarkers (Tumor Markers)IBA 03/2006
1	AlbuminsIBA 12/2001
1	Hormones (Hormone)IBA 09/2001
1	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 09/2001
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 08/2001
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 08/2001
1	Octreotide (Sandostatin)FDA LinkGeneric 08/2001
1	lanreotide (Somatuline)FDA Link 08/2001
1	2,3-dihydroxybenzoic acidIBA 04/2001
1	Proline (L-Proline)FDA Link 04/2001
1	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2001
1	RNA (Ribonucleic Acid)IBA 03/2001
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 03/2001
1	AntibodiesIBA 03/2001
1	GastrinsIBA 12/2000
1	ProlactinIBA 11/2000
1	1,1-diethyl-2-hydroxy-2-nitrosohydrazineIBA 07/2000
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 04/2000
1	tempolIBA 04/2000
1	nitroxylIBA 04/2000
1	Ethanol (Ethyl Alcohol)IBA 02/2000
1	GadoliniumIBA 02/2000
1	Chloroquine (Aralen)FDA LinkGeneric 01/2000
1	Tf-CRM107IBA 01/2000
1	Indicators and Reagents (Reagents)IBA 01/2000
1	Corticotropin-Releasing HormoneIBA 01/2000
1	Hemoglobins (Hemoglobin)IBA 01/2000
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2000
1	Arginine (L-Arginine)FDA Link 01/2000

Therapy/Procedure

4	Therapeutics 12/2001 - 01/2000
1	Immunotherapy 12/2001
1	Contraindications 06/2000
1	Sutures (Suture) 04/2000
1	Aftercare (After-Treatment) 02/2000
1	Intralesional Injections 02/2000
1	Intravenous Infusions 01/2000